A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen
Clinical trial NCT02066636 · COMPLETED
Trial details
- NCT number
- NCT02066636
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-09
- Primary completion
- 2021-10-06
- Enrollment
- 1428
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.